Evidence map›Paper›PMID 34554489›Full record

ArticleBiologia futura2021

Interactions between probiotic and oral pathogenic strains.

Noémi N Gönczi, Orsolya Strang, Zoltán Bagi, Gábor Rákhely, Kornél L Kovács

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Biologia futura, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06063239 (Probiotics in Special Needs Patients at High Risk for Tooth Decay), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06063239 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Probiotics in Special Needs Patients at High Risk for Tooth Decay: a Randomized Controlled Trial.

TypeinterventionalSponsorG. d'Annunzio UniversityRan2023 to 2024Enrolled70ConditionsTooth Decay, Intellectual Disability, Caries,DentalArmsTest Group, Positive Control, Negative Control
3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Oral Administration of Freeze-DriedFood science & nutrition · 2026
    Article
  5. Article
  6. Article
  7. Mechanism of Action ofAntibiotics (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Growth Conditions InfluenceBiomedicines · 2023
    Article
  10. In Vitro Selection ofInternational journal of molecular sciences · 2022
    Article
  11. Article
  12. Complete Genome Sequence ofMicrobiology resource announcements · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Noémi N GöncziDepartment of Biotechnology, University of Szeged, Közép fasor 52., Szeged, 6726, Hungary. nikolett.noemi.gonczi@gmail.com.
Orsolya StrangDepartment of Biotechnology, University of Szeged, Közép fasor 52., Szeged, 6726, Hungary.
Zoltán BagiDepartment of Biotechnology, University of Szeged, Közép fasor 52., Szeged, 6726, Hungary.
Gábor RákhelyDepartment of Biotechnology, University of Szeged, Közép fasor 52., Szeged, 6726, Hungary.
Kornél L KovácsDepartment of Biotechnology, University of Szeged, Közép fasor 52., Szeged, 6726, Hungary.

Funding

Emberi Eroforrások Minisztériuma EFOP-3.6.2-16-2017-00010Nemzeti Kutatási, Fejlesztési és Innovaciós Alap GINOP-2.2.1-15-2017-00081Nemzeti Kutatási, Fejlesztési és Innovaciós Alap GINOP-2.3.2-15-2016-00011Nemzeti Kutatási, Fejlesztési és Innovaciós Alap NKFIH FK123902
6 · The paper itself

Abstract

More than 6 billion bacteria and other microorganisms live in the adult oral cavity. As a result of any deleterious effect on this community, some microorganisms will survive better than others, which may trigger pathogenic processes like caries, halitosis, gingivitis or periodontitis. Oral dysbiosis is among the most frequent human health hazards globally. Quality of life of patients deteriorates notably, while treatments are often unpleasant, expensive and irreversible, e.g. tooth loss. In the experiments reported here, we investigated the individual interactions between 8 pathogenic and 8 probiotic strains and a commercially available probiotic product. Almost all pathogens, namely Fusobacterium nucleatum, Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, Streptococcus mutans, Streptococcus oralis, Streptococcus gordonii, Enterococcus faecalis and Prevotella buccae are pathogens frequently occurring in the oral cavity. The used probiotic strains were Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus casei, Lactobacillus acidophilus, Lactobacillus delbrueckii, Bifidobacterium thermophilum and two Streptococcus dentisani isolates. Using a modified agar diffusion method, we investigated capability of the probiotic bacteria to prevent the growth of the pathogenic ones in order to identify candidates for future therapeutic treatments. The results indicated successful bacteriocin production, i.e. growth inhibition, against every pathogenic bacterium by at least 5 probiotic strains.

Indexed as

AntibiosisHumansMouthPeriodontitisProbioticsVirulence FactorsVirulence FactorsBacteriocinDysbiosisModified agar diffusion testOral diseases

Identifiers

PMID34554489

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.